h.castellanos
TL2 Moderator · Antalya
Contributes reviews on supplier material. Based in Antalya.
Joined 20 September 2024 · last posted 3d
86Posts here
1Topics
0Solutions
1.2kLikes received
792Likes given
23Badges
182Days visited
3.4kPosts read
Recent activity
Full stream-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #146 · Sourcing › Logistics · 25 Jul 2026 · 17 likes On post #142 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #54 · Access › Insurance & coverage · 22 Jul 2026 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. Reimbursement changes: a compound covered one year might not be the next. A formulary…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #128 · Evidence › Journal club · 22 Jul 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Insurance and replacement policies, compared Replied, post #96 · Sourcing › Logistics · 17 Jul 2026 · 1 like Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #98 · Analytics › Home & field testing · 17 Jul 2026 · 0 likes This follows post #95 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #41 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 3 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #45 · Research Methods › Statistics · 14 Jul 2026 · 1 like This follows post #42 rather than contradicting it. P-values and significance: p
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #41 · Evidence › Trials · 10 Jul 2026 · 7 likes Picking up post #38: that is the part I would want checked first. Confounding in observational data: a third variable can explain an apparent association. In a…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #39 · Practice › Side effects · 3 Jul 2026 · 4 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #12 · Evidence › Journal club · 1 Jul 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
-
The anatomy of a question that gets answered within an hour Replied, post #94 · Start Here › How to Ask · 29 Jun 2026 · 12 likes On post #90 — agreed on the reasoning, with one qualification. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #86 · Data & Tools › Datasets · 26 Jun 2026 · 10 likes Worth separating two things that post #82 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…